XML 50 R36.htm IDEA: XBRL DOCUMENT v3.22.2.2
Employee Benefits (Tables)
12 Months Ended
Sep. 30, 2022
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule Of Share Based Payment Award Stock Options Valuation Assumptions
We have elected to use the Black-Scholes option pricing model to determine grant-date fair value for stock options, with the following assumptions: (i) expected share price volatility based on the average of Meridian’s historical volatility over the options’ expected lives and implied volatility based on the value of tradable call options; (ii) expected life of options based on contractual lives, employees’ historical exercise behavior and employees’ historical post-vesting employment termination behavior; (iii) risk-free interest rates based on treasury rates that correspond to the expected lives of the options; and (iv) dividend yield based on the expected yield on underlying Meridian common stock. A summary of these key assumptions are as follows:
 
Year ended September 30,
  
2022
 
  
2021
 
 
2020
 
Share price volatility
  
 
51%-59%
 
    
53%-59
% 
     34 % 
Life of option
  
 
4.00-7.06 yrs.
 
    
4.00-7.47 yrs.
 
     6.51 yrs.  
Risk-free interest rates
  
 
0.95%-1.73%
 
     0.26%-0.79
% 
     1.60 %
Dividend yield
  
 
0%
 
     0
% 
     0  %
Summary of Stock Option Plans
A summary of the status of our stock option plans as of September 30, 2022, and changes during the year ended September 30, 2022, is presented in the table and narrative below:
 
     Options      Wtd Avg
Exercise
Price
     Wtd Avg
Remaining
Life (Yrs)
     Aggregate
Intrinsic
Value
 
Outstanding beginning of period
     1,001      $ 15.31                    
Grants
     163        19.52                    
Exercises
     (186 )       13.27                    
Forfeitures
     —          —                      
Cancellations
     (9 )       20.26                    
    
 
 
    
 
 
    
 
 
    
 
 
 
Outstanding end of period
     969      $ 16.55        6.19      $ 14,515  
    
 
 
    
 
 
    
 
 
    
 
 
 
Exercisable end of period
     612      $ 16.62        4.97      $ 9,124  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
Summary of Nonvested Options
A summary of the status of our nonvested options as of September 30, 2022, and changes during the year ended September 30, 2022, is presented below:
 
 
  
Options
 
  
Weighted-
Average
Grant Date
Fair Value
 
Nonvested beginning of period
     403      $ 5.70  
Granted
     163        9.26  
Vested
     (209 )       5.73  
Forfeitures
     —          —    
    
 
 
    
 
 
 
Nonvested end of period
     357      $ 7.30